Cargando…

FDA-Approved Drugs that Protect Mammalian Neurons from Glucose Toxicity Slow Aging Dependent on Cbp and Protect Against Proteotoxicity

Screening a library of drugs with known safety profiles in humans yielded 30 drugs that reliably protected mammalian neurons against glucose toxicity. Subsequent screening demonstrated that 6 of these 30 drugs increase lifespan in C. elegans: caffeine, ciclopirox olamine, tannic acid, acetaminophen,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lublin, Alex, Isoda, Fumiko, Patel, Harshil, Yen, Kelvin, Nguyen, Linda, Hajje, Daher, Schwartz, Marc, Mobbs, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218048/ https://www.ncbi.nlm.nih.gov/pubmed/22114686 http://dx.doi.org/10.1371/journal.pone.0027762

Ejemplares similares

Role of CBP and SATB-1 in Aging, Dietary Restriction, and Insulin-Like Signaling
por: Zhang, Minhua, et al.
Publicado: (2009)

Clusterin protects neurons against intracellular proteotoxicity
por: Gregory, Jenna M., et al.
Publicado: (2017)

Coordination between aminoacylation and editing to protect against proteotoxicity
por: Zhang, Hong, et al.
Publicado: (2023)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection
por: Cohen, Ehud, et al.
Publicado: (2010)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model
por: Fett, Mareike E., et al.
Publicado: (2010)

Crosstalk between cellular compartments protects against proteotoxicity and extends lifespan
por: Perić, Matea, et al.
Publicado: (2016)

Hyperactivation of the proteasome in Caenorhabditis elegans protects against proteotoxic stress and extends lifespan
por: Anderson, Raymond T., et al.
Publicado: (2022)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
por: Yang, Fan, et al.
Publicado: (2023)

ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity
por: Gerhardt, Maximilian J, et al.
Publicado: (2017)

The intrinsic chaperone network of Arabidopsis stem cells confers protection against proteotoxic stress
por: Llamas, Ernesto, et al.
Publicado: (2021)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

A Comprehensive Map of FDA-Approved Pharmaceutical Products
por: Zhong, Hao, et al.
Publicado: (2018)

THPdb: Database of FDA-approved peptide and protein therapeutics
por: Usmani, Salman Sadullah, et al.
Publicado: (2017)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Immunotherapy for Breast Cancer: First FDA Approved Regimen
por: Soare, Georgiana R., et al.
Publicado: (2019)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
por: Gherghescu, Ioana, et al.
Publicado: (2020)

FDA efficiency for approval process of COVID-19 therapeutics
por: Cassidy, Christine, et al.
Publicado: (2020)

MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells
por: Oh, Jaehak, et al.
Publicado: (2018)

NEDDylation promotes nuclear protein aggregation and protects the Ubiquitin Proteasome System upon proteotoxic stress
por: Maghames, Chantal M., et al.
Publicado: (2018)

The CRTC-CREB axis functions as a transcriptional sensor to protect against proteotoxic stress in Drosophila
por: Yin, Youjie, et al.
Publicado: (2022)

Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection
por: Liccardo, Francesca, et al.
Publicado: (2023)

Fluphenazine Reduces Proteotoxicity in C. elegans and Mammalian Models of Alpha-1-Antitrypsin Deficiency
por: Li, Jie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f9epfenm411s42gd38vn6mgv51